Jorge Sierra
Affiliations: | 1977 | Chemistry | Universität Zürich, Zürich, ZH, Switzerland |
Google:
"Jorge Sierra"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baron F, Nagler A, Galimard JE, et al. (2023) Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study. British Journal of Haematology |
| Nagler A, Labopin M, Cornelissen JJ, et al. (2022) Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation |
| Sheth V, Volt F, Sanz J, et al. (2020) Reduced-intensity versus myeloablative conditioning in cord blood transplantation for AML (40-60 years) across highly mismatched HLA barriers - On behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation |
| Baron F, Labopin M, Ruggeri A, et al. (2020) Impact of detectable measurable residual disease on umbilical cord blood transplantation. American Journal of Hematology |
| Díaz-Beyá M, Labopin M, Maertens J, et al. (2020) Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remission. British Journal of Haematology |
| Penack O, Peczynski C, van der Werf S, et al. (2019) Association of uric acid levels before start of conditioning with mortality after alloSCT: a prospective, non-interventional study of the EBMT Transplant Complication Working Party. Haematologica |
| Novelli S, Bento L, García-Cadenas I, et al. (2019) Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime Blood. 134: 3325-3325 |
| Ortí G, Sanz J, García-Cadenas I, et al. (2018) Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions. Experimental Hematology |
| Bazarbachi A, Boumendil A, Finel H, et al. (2018) Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party. British Journal of Haematology |
| Robinson SP, Boumendil A, Finel H, et al. (2018) Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party. Bone Marrow Transplantation |